Seeing Is Believing
Currently out of the existing stock ratings of Bradley Canino, 161 are a BUY (80.9%), 38 are a HOLD (19.1%).
Analyst Bradley Canino, currently employed at GUGGENHEIM, carries an average stock price target met ratio of 37.15% that have a potential upside of 47.68% achieved within 167 days. Previously, Bradley Canino worked at CREDIT SUISSE, STIFEL.
Bradley Canino’s has documented 369 price targets and ratings displayed on 27 stocks. The coverage is on Healthcare, Energy sectors.
Most recent stock forecast was given on ORIC, Oric Pharmaceuticals at 12-Jun-2026.
Analyst best performing recommendations are on GLTO (GALECTO ).
The best stock recommendation documented was for SMMT (SUMMIT THERAPEUTICS PLC) at 9/9/2024. The price target of $25 was fulfilled within 3 days with a profit of $5.86 (30.62%) receiving and performance score of 102.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Mar-2022
$4
$1.96 (96.08%)
6 months 4 days ago
(10-Mar-2026)
2/8 (25%)
$1.96 (96.08%)
203
Hold Since 01-Aug-2024
$1.5
$-0.54 (-26.47%)
$3
1 years 6 months 7 days ago
(07-Mar-2025)
3/8 (37.5%)
$0.44 (41.51%)
324
Buy Since 11-Aug-2020
$21
1 years 6 months 8 days ago
(06-Mar-2025)
3/9 (33.33%)
$12.33 (142.21%)
34
Hold Since 06-Mar-2025
$3
$0.96 (47.06%)
1 years 6 months 8 days ago
(06-Mar-2025)
1/5 (20%)
$1.69 (129.01%)
93
Buy Since 09-Aug-2022
1 years 7 months 21 days ago
(24-Jan-2025)
0/4 (0%)
$16.62 (260.50%)
Which stock is Bradley Canino most bullish on?
Which stock is Bradley Canino most reserved on?
What Year was the first public recommendation made by Bradley Canino?